By Hidden Values Daily Four biotech stocks in the IBD 50 are in bases as first-quarter earnings rolls in. Travere Therepeutics is below a buy point of 42.13.
Source: https://www.investors.com/stock-lists/ibd-50/biotech-travere…
Four Biotech Stocks Near Buy Points As Earnings Season Kicks In
